Please login to the form below

Not currently logged in
Email:
Password:

Sanofi Genzyme

This page shows the latest Sanofi Genzyme news and features for those working in and with pharma, biotech and healthcare.

Dupixent helps put Sanofi back on growth track

Dupixent helps put Sanofi back on growth track

Gains for vaccine division Sanofi Pasteur and the company’s specialty medicines division, which along with Dupixent includes Genzyme’s rare disease drugs and multiple sclerosis therapies like Aubagio (teriflunomide), contributed ... Buoyed by an 8%

Latest news

  • Sanofi gets EU OK for Ablynx flagship drug Cablivi Sanofi gets EU OK for Ablynx flagship drug Cablivi

    Sanofi gets EU OK for Ablynx flagship drug Cablivi. EMA clears the drug to treat adults with aTTP. ... Sanofi reckons there are around 7, 500 patients with aTTP across the US, the EU and Japan.

  • Sanofi’s rare blood disorder drug Cablivi set for European approval Sanofi’s rare blood disorder drug Cablivi set for European approval

    Rare disease drug among notable CHMP recommendations. Sanofi is closing in on EU approval of Cablivi for acquired thrombotic thrombocytopenic purpura (aTTP) – the lead asset behind its 9.3bn acquisition of ... Europe looks set to be the first market

  • Communiqué 2018 - all the winners Communiqué 2018 - all the winners

    Excellence in Communications via Meetings. OptiMiSe: an Innovative Meetings-based Learning Journey for Clinical Behaviour Change Among Multiple Sclerosis Specialist Nurses by Lucid for Sanofi Genzyme. ... Excellence in Corporate Communications –

  • Lucid’s “spellbinding” performance prompts multiple wins at Communiqué 2018 Lucid’s “spellbinding” performance prompts multiple wins at Communiqué 2018

    Meanwhile, Lucid’s work in multiple sclerosis (MS) for Sanofi Genzyme triggered another win for the group in the Excellence in Communications via Meetings category.

  • The year of the blockbuster The year of the blockbuster

    Patisiran from Alnylam and Sanofi: Patisiran is an intravenously administered RNAi therapeutic targeting the transthyretin gene for the treatment of patients with debilitating hereditary transthyretin-mediated amyloidosis. ... Together with the Genzyme

More from news
Approximately 15 fully matching, plus 81 partially matching documents found.

Latest Intelligence

  • Trust me, I’m from pharma Trust me, I’m from pharma

    Rather than assuming anything, Sanofi Genzyme took a step back and asked patients: how can we help? ... In Sanofi Genzyme’s case, it culminated in a set of briefs that were owned by the patients living with the disease.

  • Medius Deal Watch table for February 2015 Medius Deal Watch table for February 2015

    Voyager Therapeutics/ Sanofi (Genzyme). Gene therapy - Parkinson's disease, Friedreich's ataxia and Huntington's disease.

  • Pharma deals during January 2014 Pharma deals during January 2014

    The other deal announced by Alnylam was the expansion of its deal with Sanofi (Genzyme unit_ to develop RNAi therapeutics in rare diseases. ... In 2008 Genzyme gained rights to ataluren from PTC Therapeutics at a cost of $100m.

  • Interview: Laure Thibaud, Sanofi Interview: Laure Thibaud, Sanofi

    overnight.”. The Genzyme deal, for which Thibaud was involved in the pre-acquisition stage of the agreement, as well as the company's subsequent integration into Sanofi, was particularly exciting, she ... Chris Viehbacher has said too that he was very

  • Who tops the pharma list? Who tops the pharma list?

    The latter, an antiplatelet agent it co-marketed with Sanofi, enjoyed 2011 sales of $9.4bn - but, with Plavix accounting for more than a third of BMS revenues in 2010, the ... For example, Sanofi's 2011 acquisition of Genzyme gave it access to an

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest appointments

  • Sobi names Holly May VP of sales and marketing, US Sobi names Holly May VP of sales and marketing, US

    at Sanofi Genzyme. ... Prior to her 17-year career at Sanofi, May held various sales positions at DuPont Pharmaceuticals and Endo.

  • Sanofi appoints Bill Sibold to lead its Genzyme business Sanofi appoints Bill Sibold to lead its Genzyme business

    Sanofi has appointed Bill Sibold as executive vice president for Sanofi Genzyme in a move that will also see he join the company's executive committee. ... Previously head of Sanofi Genzyme’s multiple sclerosis, oncology and immunology organisation,

  • Dr Irina Antonijevic joins vasopharm Dr Irina Antonijevic joins vasopharm

    Most recently, Dr Antonijevic served as global head of early development in neurology, multiple sclerosis and ophthalmology at Sanofi Genzyme in the US.

  • ImmuneXcite boosts senior leadership ImmuneXcite boosts senior leadership

    Genzyme. DeWitt is senior director of investments at Sanofi-Genzyme BioVentures and brings business leadership experience from Springboard Enterprises, Permeon Biologics and Flagship Ventures. ... He is chairman of the board of Idera Pharmaceuticals and

  • Former Genzyme group vice president joins Vedanta Biosciences Former Genzyme group vice president joins Vedanta Biosciences

    Former Genzyme group vice president joins Vedanta Biosciences. Dr Bruce Roberts takes up the role of chief scientific officer. ... He first joined Sanofi Genzyme as general manager of its Cambridge, UK-based therapeutic antibody centre in 2004 before

More from appointments
Approximately 1 fully matching, plus 9 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency comprising specialists with some of the best skills,...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics